Most recent update: Friday, May 25, 2018 - 09:41

Bariatric News - Cookies & privacy policy

- News

Researchers investigating the legality of on-pack nutrition and health claims routinely found on commercially available meal replacement shakes for sale in the UK, but that more than three-quarters are unauthorised and do not comply with the EU... (more)

25/05/18 - News

The daily use of a novel nasal device to reduce the user’s ability to smell can induce weight loss and changes to dietary preferences in people aged 50 years and under, according to a study conducted by Dr Dror Dicker, Hasharon Hospital, Rabin Medical Center, Petah Tikva, Israel... (more)
24/05/18 - News

Researchers from Norway have reported that putting no weight increases the risk of cancer for middle-aged women.  The results of the study were presented at the European Congress on Obesity, in Vienna, Austria. The study, which tracked more than 137,000 Norwegian women for 18... (more)
24/05/18 - News

Some 15,000 new cancer cases are diagnosed in Brazil each year, and researchers have reported that approximately 4 percent of these cases could be avoided by reducing overweight and obesity. The epidemiological study was conducted by scientists at the Preventive Medicine... (more)

Abdominal fat

25/05/18

An international research team has identified a novel adipokine that favours the development of insulin resistance and systemic inflammation,...

23/05/18 - News

Successful weight loss maintainers have different behavioural and physiological responses to food than people with obesity and their lean counterparts, according to research by the University of Birmingham and the University of Amsterdam presented at this year's European... (more)
23/05/18 - News

Spanish researchers have developed a new food-based score that is strongly associated with long-term risk of overweight or obesity across adulthood, according to research being presented at this year's European Congress on Obesity in Vienna, Austria.
23/05/18 - News

In 27 years from now, almost a quarter of the global population will be obese, according to research presented at the European Congress on Obesity in Vienna, if current trends continue 22 percent of people in the world will be obese by 2045, up from 14 percent in 2017. In... (more)

More news

23/05/18 - Research
Obesity epidemic
In 27 years from now, almost a quarter of the global population will be obese, according to research presented at the European Congress on Obesity in Vienna, if current trends continue 22 percent of people in the world will be obese by 2045, up from 14 percent in 2017. In addition, one in eight... (more)
22/05/18 - Research
Obsogens
Everyday products carry environmental chemicals that may be making us fat by interfering with our hormones, according to research presented in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018.  Following recommendations on how to avoid these chemicals could help minimise... (more)
22/05/18 - Research
Intermittent fasting diets
Fasting every other day to lose weight impairs the action of sugar-regulating hormone, insulin, which may increase diabetes risk, according to data presented in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018. These findings suggest that fasting-based diets may be... (more)
21/05/18 - Research
Vitamin D deficiency
Higher levels of belly fat are associated with lower vitamin D levels in obese individuals, according to data presented in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018. The study reports that vitamin D levels are lower in individuals with higher levels of belly fat,... (more)
21/05/18 - Research
deep Transcranial Magnetic Stimulation
Stimulating the brain to alter its intrinsic reward system shows promise in the treatment of obesity, according to results presented in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018. The technique has yielded positive results after just a single treatment session,... (more)
21/05/18 - Industry
Semaglutide and T2DM
Semaglutide is safe and effective for the treatment of type 2 diabetes, according to a review by researchers from the Aristotle University of Thessaloniki, Greece. The researchers found that semaglutide is a potent once‐weekly GLP‐1 RA, reducing significantly HbA1c, body weight and systolic blood... (more)